【制药网 行业动态】根据医药行业企业发布的2025年半年度财报显示，强生、罗氏、默沙东、艾伯维、辉瑞、礼来、阿斯利康、诺华、拜耳、BMS等企业在上半年营收方面排名靠前。强生今年半年度财报显示，2025年上半年公司营收同比增长4.1%，达到456.36亿美元。财报显示，肿瘤业务成为强生大的增长引擎，上半年收入达119.90亿美元，同比+21.1%，其中传奇CAR-T疗法增长翻倍，据悉，公司与传奇生物...
Source Link【制药网 行业动态】根据医药行业企业发布的2025年半年度财报显示，强生、罗氏、默沙东、艾伯维、辉瑞、礼来、阿斯利康、诺华、拜耳、BMS等企业在上半年营收方面排名靠前。强生今年半年度财报显示，2025年上半年公司营收同比增长4.1%，达到456.36亿美元。财报显示，肿瘤业务成为强生大的增长引擎，上半年收入达119.90亿美元，同比+21.1%，其中传奇CAR-T疗法增长翻倍，据悉，公司与传奇生物...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.